TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›HCSG

HCSG

HEALTHCARE SERVICES GROUP INC

Next earnings Jul 21, 2026 (before open) · consensus $0.23 EPS, $481M rev

Last earnings +18.3% on 2026-04-22

Hold
$25.15
▲ +2.65%
$25.15▲ +68.45%
over 1Y
L $12.69H $25.15
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.7%
1W+6.4%
1M+24.3%
3M+37.1%
YTD+45.0%
1Y+68.5%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B
Valuation
Undervalued
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 12 analysts
Buy

Market-leading but razor-thin-margin services play; 2025 earnings/cash surge is real but the 30x P/E already pays for it.

Diluted EPS $0.81 · FY2025

The read

Middling fundamentals offset by an attractive price (~22% below fair value) — worth a look on the value angle.

HCSG is the largest provider of housekeeping, laundry and dietary management to U.S. long-term-care facilities (~2,800 sites), and FY2025 was a genuine inflection: revenue grew 7.1% to $1.84B after four years stuck near $1.65–1.72B, net income jumped 49.6% to $59.1M, diluted EPS rose 52.8% to $0.81, and ROE recovered to 11.6%. The balance sheet is a real strength — $125M cash (up 120%), $510M equity, a 3.4x current ratio ($576M vs $170M), and a capital-light model ($5.82M capex against $145M operating cash flow). Management returned aggressively, buying back $61.6M of stock (shares down 4.4%) with no dividend.

The quality caveats are equally concrete. Net margin is only 3.2% — there is almost no cushion in this labor- and supply-cost-driven business. The filing is explicit that wage inflation and minimum-wage hikes cannot all be automatically passed through, and that dietary/EVS supply costs (now pressured by new tariffs) often pass through only at the next scheduled billing review, creating timing drags on margin. Customer contracts are cancellable on just 30–90 days' notice, and the customer base is financially stressed nursing homes — so revenue durability is structurally fragile. The +370% jump in operating cash flow signals an abnormally weak prior year and a working-capital normalization, so I would not treat $145M OCF as a clean run-rate.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 5:33 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$1.64B$1.69B$1.67B$1.72B$1.84B
Gross profit—————
Operating income—————
Net income$48.5M$34.2M$38.4M$39.5M$59.1M
Diluted EPS$0.65$0.46$0.52$0.53$0.81
Net margin3.0%2.0%2.3%2.3%3.2%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$1.60B
EV / EBITDA—
EV / Sales0.9
EV / FCF11.5
P / FCF12.4
PEG (trailing)0.63
Earnings yield3.4%
FCF yield8.1%

Quality & risk

ROIC (est.)—
Free cash flow$139M
Total debt—
Net cash$125M
Piotroski F-Score7/7

Capital returns

Buyback yield3.6%
Dividend yield (est.)0.0%
Shareholder yield3.6%
Shares Δ YoY-4.4%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Shareholder vote2026-05-27

    Annual meeting vote results (director elections, say-on-pay); no surprises

  2. 10-Q Quarterly report2026-04-24

    Q1 2026 (period 3/31): revenue growth continues, EPS $0.81 TTM, cash $125M

  3. 8-K Earnings results2026-04-22

    Q1 2026 earnings release; momentum from record FY25 profitability

  4. DEF 14A Proxy statement2026-04-15

    Annual proxy: director slate, exec comp, auditor ratification

  5. 8-K Material agreement2026-04-13

    Entered new credit facility, creating direct financial obligation

  6. 10-K Annual report2026-02-13

    FY25: rev $1.84B +7.1%, NI $59.1M +49.6%, OCF +371%, $61.6M buybacks

  7. 8-K Earnings results2026-02-11

    FY25 earnings release: net income +49.6%, EPS +52.8%, cash flow surged

  8. 10-Q Quarterly report2025-10-24

    Q3 2025 quarterly results, contributing to record full-year

  9. 8-K Earnings results2025-10-22

    Q3 2025 earnings release; on track within strong FY25

Recent filings

all on EDGAR ↗
4Period ending 2026-07-012026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4/APeriod ending 2026-05-272026-05-29open ↗4Period ending 2026-05-262026-05-28open ↗4Period ending 2026-05-262026-05-28open ↗4Period ending 2026-05-262026-05-28open ↗4Period ending 2026-05-262026-05-28open ↗4Period ending 2026-05-262026-05-28open ↗4Period ending 2026-05-262026-05-28open ↗4Period ending 2026-05-262026-05-28open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueB-
GrowthA-
ProfitabilityC
Financial healthA-
MomentumA+
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗P/E below 25

Fair value est.

$30.78

Undervalued +22% vs price

cheapfair valueexpensive

Modified Graham: EPS $0.81 × (8.5 + 1.5 × 22.0% growth) × 0.95 quality = 38.0× multiple. An estimate, not a price target.

12.6952-week25.15
Revenue
$1.84B
+7.1% YoY
Net margin
3.2%
ROE
11.6%
P/E
31.0

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$1.84B+7.1%
Net income$59.1M+49.6%
Diluted EPS$0.81+52.8%
Cash & equivalents$125M+120.5%
Total assets$794M-1.1%
Stockholders' equity$510M+2.1%

Frequently asked

Is HEALTHCARE SERVICES GROUP INC (HCSG) a buy?
HCSG currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Market-leading but razor-thin-margin services play; 2025 earnings/cash surge is real but the 30x P/E already pays for it.
What is HCSG's fair value?
A Modified-Graham model based on HCSG's SEC fundamentals estimates a fair value of about $30.78. It is an estimate from reported earnings, not a price target.
Is HCSG overvalued or undervalued?
Against a Modified-Graham fair-value estimate, HCSG currently appears undervalued relative to its SEC-grounded earnings power.
What is HEALTHCARE SERVICES GROUP INC's quality score?
HCSG scores 74.42295918367347/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000731012, latest 10-Q filed 2026-04-24) · EODHD · Proprietary analysis · as of 6/30/2026, 9:33:43 AM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-07-01
Brophy Andrew M
SVP & Chief Accounting Officer
Award4.38K
2026-06-30
Grant Laura K
Director
Award306.00 @ $24.56$7.52K
2026-06-30
WHALEN THOMAS GERARD
Director
Award102.00 @ $24.56$2.51K
2026-06-30
Simmons Kurt JR
Director
Award611.00 @ $24.56$15.0K
2026-05-26
WHALEN THOMAS GERARD
Director
Award1.97K @ $20.32$40.0K
2026-05-26
Gallagher Thomas Michael
Director
Award1.97K @ $20.32$40.0K
2026-05-26
Ottaviano Dino D
Director
Award1.97K @ $20.32$40.0K
2026-05-26
Simmons Kurt JR
Director
Award1.97K @ $20.32$40.0K

Dividends

Irregular
Yield (TTM)
—
Annual / share
—
Last ex-date
2022-11-17
Last amount
$0.22
ex 2022-11-17paid 2022-12-22$0.22
ex 2022-08-18paid 2022-09-23$0.21
ex 2022-05-19paid 2022-05-24$0.21
ex 2022-02-24paid 2022-03-25$0.21
ex 2021-11-18paid 2021-12-23$0.21
ex 2021-08-19paid 2021-09-24$0.21

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-22Beat +74.4% est▲ +18.29%8-K ↗
2026-02-11Beat +87.6% est▲ +15.80%8-K ↗
2025-10-22Beat +189.2% est▲ +13.76%8-K ↗
2025-07-23Beat +1.3% est▲ +12.11%8-K ↗
2025-04-23—▲ +29.54%8-K ↗
2025-02-12—▼ -1.79%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2020-05-07Greg GianforteBuy$50.0K–$100KPTR ↗
2019-11-27Greg GianforteBuy$100K–$250KPTR ↗
2019-10-20Greg GianforteSell$100K–$250KPTR ↗
2019-05-14Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2019-04-16Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2018-03-27Greg GianforteBuy$15.0K–$50.0KPTR ↗
2017-07-19Greg GianforteSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
Concentrix Corporation (CNXC) Misses Q2 Earnings and Revenue EstimatesBullish
finance.yahoo.com· 2026-06-29
Healthcare Services Group, Inc. (HCSG) Hits Fresh High: Is There Still Room to Run?Bullish
finance.yahoo.com· 2026-06-29
HCSG Q1 2026 Earnings Call TranscriptBullish
nasdaq.com· 2026-06-02
New Strong Buy Stocks for May 22ndBullish
finance.yahoo.com· 2026-05-22
Has Healthcare Services Group (HCSG) Outpaced Other Business Services Stocks This Year?Bullish
finance.yahoo.com· 2026-05-21
Zacks.com featured highlights include Healthcare Services, Electromed, UMB Financial, Shell and MACOM Technology SolutionsBullish
finance.yahoo.com· 2026-05-18

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score74 vs 67
Revenue growth7.1% vs 7.5%
Net margin3.2% vs 10.0%
Return on equity11.6% vs 12.0%
P/E31.0 vs 26.2

News sentiment

EODHD · 8d
Bullish
+0.17
vs typical · 10 articles

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.